DRTX

Durata Therapeutics, Inc. News Headlines

$23.82
*  
0.27
1.12%
Get DRTX Alerts
*Delayed - data as of Oct. 22, 2014  -  Find a broker to begin trading DRTX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Bloomberg: Actavis Among Final-stage Bidders For Omega Pharmaceuticals
10/20/2014 10:49:00 PM - RTT News


Medical Properties To Buy 40 Rehabilitation Hospitals In Germany For $900 Mln
10/20/2014 10:48:00 PM - RTT News


Merger Arbitrage Mondays - October 13, 2014
10/13/2014 12:13:00 PM - Seeking Alpha


Actavis plc and Valeant Pharmaceuticals Inc. Battle for Allergan Inc.: Who Wins?
10/9/2014 3:52:30 PM - Motley Fool


Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene
10/7/2014 6:33:00 PM - Investor's Business Daily


Actavis in Acquisition Mode, Durata Deal to Boost Portfolio - Analyst Blog
10/7/2014 5:42:00 PM - Zacks.com


Stock Market News for October 07, 2014 - Market News
10/7/2014 10:10:00 AM - Zacks.com


ACT Opens Wallet, ADHD Craters, CMRX Focuses On Ebola, REGN Gets FDA Nod
10/7/2014 4:37:00 AM - RTT News


Sector Update: Health Care Stocks Drifting Lower; Durata Therapeutics Climbs to Record High Following Actavis Buyout Offer
10/6/2014 2:07:50 PM - MT Newswires


Sector Update: Health Care
10/6/2014 1:56:32 PM - MT Newswires


Why Durata Therapeutics Inc. Is Today's Best Biotech Stock
10/6/2014 1:34:02 PM - Motley Fool


Why Durata Therapeutics (DRTX) Stock Hit a One-Year High Today
10/6/2014 10:20:00 AM - TheStreet


Durata Therapeutics, Inc. (DRTX) Surges: Stock Rises 17.3% - Tale of the Tape
10/6/2014 9:11:00 AM - Zacks.com


Actavis To Acquire Durata Therapeutics In $675 Mln Deal
10/6/2014 9:01:00 AM - RTT News


Actavis Subsidiary To Acquire Durata Therapeutics
10/6/2014 8:18:00 AM - RTT News


Sector Update: Health Care Stocks Leading Markets Into the Close; Durata Therapeutics Rises After Reaching Accord with FDA
10/3/2014 4:01:21 PM - MT Newswires


Sector Update: Health Care
10/3/2014 3:59:32 PM - MT Newswires


Durata: FDA Grants Special Protocol Agreement For DALVANCE Phase 3 Study
10/3/2014 8:13:00 AM - RTT News


Commit To Purchase Durata Therapeutics At $10, Earn 17.1% Annualized Using Options
10/2/2014 11:28:51 AM - BNK Invest


Did The Medicines Company Trump Cellceutix And Others In A $1B-Plus Skin Infection Market?
8/14/2014 11:38:00 AM - Seeking Alpha


What Makes Durata Therapeutics (DRTX) a Strong Sell? - Tale of the Tape
8/13/2014 8:44:04 AM - Zacks.com


BDSI Hoping To Deliver, MDCO Gets FDA Nod, TXMD On Watch, Busy Days Await NVAX
8/7/2014 12:50:00 AM - RTT News


Durata Therapeutics (DRTX) Worth Watching: Stock Gains 18.5% - Tale of the Tape
8/5/2014 9:46:00 AM - Zacks.com


CytoDyn On Watch List, FDA Panel Snubs EDAP, CRY Makes Investors Smile
7/31/2014 12:32:00 AM - RTT News


United Therapeutics (UTHR) Jumps: Stock Adds 8.1% in Session - Tale of the Tape
7/30/2014 8:37:00 AM - Zacks.com